Decision: Favourable

Decisions Table

Study Title:

CONNected Electronic Inhalers Asthma Control Trial 3 (CONNECT 3), a 24-Week Treatment, Multicenter, Open-Label, Randomized, Parallel Group Comparison Study of Standard of Care Treatment Versus the Budesonide/Formoterol Digihaler Digital System, to Optim

  • NREC Code:

    22-NREC-MD-027

  • Decision:

    Favourable

  • Meeting Date:

    15/09/2022

  • Study Type:

    MD application

  • Principal Investigator:

    Prof. Richard Costello

  • PI Institution:

    Beaumont Hospital

  • Sponsor:

    Teva Branded Pharmaceutical Products R&D, Inc.

Scroll to Top